Application of microbial enzymes in medicine and industry: current status and future perspectives

被引:0
|
作者
Darbandi, Atieh [1 ]
Elahi, Zahra [2 ]
Dadgar-Zankbar, Leila [2 ]
Ghasemi, Fatemeh [3 ]
Kakavandi, Naser [4 ]
Jafari, Sajjad [5 ]
Darbandi, Talieh [6 ]
Ghanavati, Roya [7 ]
机构
[1] Shahed Univ, Mol Microbiol Res Ctr, Tehran, Iran
[2] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Pathobiol, Div Microbiol, Tehran, Iran
[4] Iran Univ Med Sci, Fac Med, Dept Biochem, Tehran, Iran
[5] Urmia Univ Med Sci, Fac Med, Dept Med Microbiol & Virol, Orumiyeh, Iran
[6] Islamic Azad Univ, Dept Pharm, Tehran Med Sci, Tehran, Iran
[7] Behbahan Fac Med Sci, Sch Med, Behbahan, Iran
关键词
classification; enzymes; industry; medical enzymes; microbial enzymes; DISORDERS CURRENT STATUS; BIOACTIVE PEPTIDES; PROTEASE; COLLAGENASE; CHALLENGES; EVOLUTION;
D O I
10.1080/17460913.2024.2398337
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Microbes are a major source of enzymes due to their ability to be mass-cultivated and genetically modified. Compared with plant and animal enzymes, microbial enzymes are more stable and active. Enzymes are generally classified into six classes based on their reaction, substrate specificity and mechanism of action. In addition to their application in medicine for treating diseases, these compounds are used as anti-inflammatory, thrombolytic and digestive agents. However, challenges such as immunogenicity, tissue specificity and short in vivo half-life make clinical trials complex. Enzymes are metabolic catalysts in industry and their production and extraction must be optimized to preserve profitability due to rising demand. The present review highlights the increasing importance of bacterial enzymes in industry and medicine and explores methods for their production, extraction and purification. PLAIN LANGUAGE SUMMARY Enzymes are important substances made by the cells of plants and animals. They are catalysts, or substances that control how quickly chemical reactions occur. These reactions are the processes that keep all plants and animals functioning. They are present in almost every natural organism, from microorganisms to plants and mammals. But plants and animals produce small amounts of enzymes unsuitable for industrial applications. The use of microbial enzymes in industry offers many advantages over plant and animal enzymes. People use enzymes in industry and medicine. Enzymes help to heal cuts and to diagnose certain diseases. They are also an important part of the process called fermentation. In industries, they are applied in the textile, starch, bakery, and detergent industries. This helps turn milk into cheese and juice into wine, and it makes bread rise before it is baked.
引用
收藏
页码:1419 / 1437
页数:19
相关论文
共 50 条
  • [41] Pharmacogenetics: Current Status and Future Perspectives
    Guchelaar, Henk-Jan
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (02) : 135 - 135
  • [42] Immunotherapy: Current Status and Future Perspectives
    Charalampos S. Floudas
    Gagandeep Brar
    Tim F. Greten
    Digestive Diseases and Sciences, 2019, 64 : 1030 - 1040
  • [43] THE ONCOGENES - CURRENT STATUS AND FUTURE PERSPECTIVES
    KOUYOUMDJIAN, JC
    FEUILHADE, F
    RYMER, JC
    RODRIGUES, LEA
    REVISTA BRASILEIRA DE MEDICINA, 1988, 45 (05) : 143 - 149
  • [44] Bedaquiline: Current status and future perspectives
    Khoshnood, Saeed
    Goudarzi, Mehdi
    Taki, Elahe
    Darbandi, Atieh
    Kouhsari, Ebrahim
    Heidary, Mohsen
    Motahar, Moloudsadat
    Moradi, Melika
    Bazyar, Hadi
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 48 - 59
  • [45] Immunotherapy: Current Status and Future Perspectives
    Floudas, Charalampos S.
    Brar, Gagandeep
    Greten, Tim F.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (04) : 1030 - 1040
  • [46] Pharmacogenomics: current status and future perspectives
    Munir Pirmohamed
    Nature Reviews Genetics, 2023, 24 : 350 - 362
  • [47] UMIN - Current status and future perspectives
    Kiuchi, T
    Igarashi, T
    MEDINFO 2004: PROCEEDINGS OF THE 11TH WORLD CONGRESS ON MEDICAL INFORMATICS, PT 1 AND 2, 2004, 107 : 1068 - 1072
  • [48] UMIN - Current Status and Future Perspectives
    UMIN Center, The University of Tokyo Hospital, Tokyo, Japan
    不详
    International Medical Informatics Association (IMIA), 1879, 1068-1072 (2004):
  • [49] Application of artificial intelligence in nuclear medicine and molecular imaging: a review of current status and future perspectives for clinical translation Response
    Kersting, David
    Sraieb, Miriam
    Fendler, Wolfgang Peter
    Buether, Florian
    Rischpler, Christoph
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (10) : 3336 - 3339
  • [50] CURRENT STATUS AND FUTURE OF FERMENTATION INDUSTRY
    MALEK, I
    PATHOLOGIA ET MICROBIOLOGIA, 1969, 34 (3-4): : 137 - &